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ABSTRACT
Background and Objectives: Radial artery spasm is one of the most common complications of transradial coronary angi-
ography (TRA): the radial artery is prone to cathecholamine-induced contraction and radial pain during TRA could in-
crease the sympathetic tone. The object of this study was to evaluate whether the eutectic mixture of local anesthesia (EMLA) 
cream, in addition to lidocaine infiltration, could reduce the sympathetic response by reducing radial pain during TRA. 
Subjects and Methods: Seventy-six patients were randomized 1 : 1 to either EMLA or control groups. Radial pain was mea-
sured by the visual analogue scale (VAS) and the verbal rating scale (VRS-4). Sympathetic response, including systolic (SBP) 
and diastolic blood pressure (DBP), pulse rate (PR), stroke volume (SV) and total peripheral resistance (TPR), was measured 
by photoplethysmography. Results: Radial pain measured during lidocaine infiltration was significantly lower in the EMLA 
group (VAS: 3.1 vs. 4.0, p=0.04; VRS-4: 2.0 vs. 2.2, p=0.03) and the sympathetic response was significantly blunted in the 
EMLA group from baseline to lidocaine infiltration (ΔSBP, mm Hg: 5 vs. 13, p<0.01; ΔDBP, mm Hg: 2 vs. 7, p=0.03; ΔPR, beat/
min: 2 vs. 8, p<0.01, ΔSV, mL: 3 vs. 21, p<0.01; ΔTPR, mm Hg · L/min: 1.0 vs. 5.9, p<0.01). Conclusion: In patients undergo-
ing TRA, the EMLA cream, in addition to lidocaine infiltration, effectively reduces the radial pain and thereby the sympa-
thetic response, during lidocaine infiltration. (Korean Circ J 2011;41:726-732)
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Introduction
Although a lower incidence of major vascular access-re-
lated complications and the potential for early mobilization 
have led to increased use of transradial coronary angiogra-
phy (TRA),
1)2) the incidence of radial artery spasm (RAS), one 
of the most common complications of TRA, was reported up 
to 30%, and was associated with patient discomfort and lower 
procedural success rates.
3-6) It has been reported that many 
factors are related to RAS, and the moderate-to-severe pain 
during radial artery cannulation is one of them.
7) The radial 
artery is prone to catecholamine-induced contraction, becau-
se it has a predominance of α adrenoceptors.
8) Therefore, any 
effort for reducing the radial pain during TRA could be benefi-
cial for preventing RAS. A eutectic mixture of local anes-
thetic cream (EMLA
®; Laboratoire ASTRA, Manterre, France), 
composed of lidocaine 2.5% and prilocaine 2.5%, is known 
to be an effective topical anesthetic agent. It is used for a va-
riety of painful cutaneous procedures on intact skin, includ-
ing phlebotomy, intravenous catheterization, arterial cannu-
lation and lumbar puncture. Previously, Kim et al.
9) have re-
ported that, when applied 1 to 3 hours before the TRA, the 
EMLA cream can effectively reduce radial pain.
The primary objective of this study was to evaluate whether 
the EMLA cream, in addition to lidocaine infiltration, could 
reduce the sympathetic response by reducing radial pain dur-
ing TRA. The secondary objective was to evaluate whether the Young Jin Youn, et al.   727
EMLA cream could improve cannulation success rate and re-
duce the RAS in the study subjects.
Subjects and Methods
Study subjects
A total of 76 individuals, who were referred for coronary 
angiography from September 2008 to March 2009, were en-
rolled in this study. All patients were randomly assigned to ei-
ther the EMLA group or the control (i.e., placebo cream) gr-
oup, by a simple randomization table. All individuals and 
the physicians performing the coronary angiographies were 
blinded as to which cream was applied. This study was ap-
proved by the local Institutional Review Board (IRB approval 
number: CR308020) and all study participants signed inform-
ed consent forms.
Application of the study cream
We provided blinded tubes containing either EMLA cream 
or placebo, which was an odorless white cream that resembled 
the EMLA cream. 1 to 3 hours before TRA, either the EMLA 
2.5 g (standard adult dose) or the placebo cream 2.5 g was ap-
plied to both wrists, 1 cm above the styloid process of the ra-
dius, and then covered with a transparent 5 cm dressing (Fig. 1). 
Radial artery cannulation and coronary angiography
All procedures were performed by the operator experienc-
ed with TRA in 1,000 or more cases in one year. 
After removing the applied cream, the radial artery was in-
filtrated with 0.6 mL of 2% lidocaine, using a 26-G needle, at 
a point located 5-10 mm proximal to the styloid process, and 
then punctured using a 20-G venous needle (Sindonbang Com-
pany, Korea). A 5-Fr 7 cm introducer sheath with hydrophilic 
coating (Terumo Company, Tokyo, Japan) was inserted into 
the radial artery. Heparin (5,000 IU) was administered into 
the radial artery via the introducer sheath. All patients under-
went coronary angiography using 4-Fr Amplatz right (Jung-
sung Medical, Korea), 4-Fr Judkins or 5-Fr Judkins (Merit-
Medical, Ireland) angiographic catheters. The puncture site and 
the shape and size of the catheters were at operator’s discretion.
Time and number of radial artery cannulations 
We defined the cannulation time as the time from lidocaine 
infiltration to the puncture of the radial artery and counted 
the number of radial artery cannulations as the number of trials 
of radial artery puncture with the 26-G needle. 
Estimating radial pain intensity
During lidocaine infiltration and introducer sheath inser-
tion, pain intensity was assessed in each patient using a visual 
analogue scale (VAS) and a 4-category verbal rating scale 
(VRS-4).
10) On the VAS, the patients indicated their pain in-
tensity by making a mark on a 10-cm long line that included 
descriptors of pain intensity labeled at each end of the line 
(e.g., from “no pain” to “pain as bad as it could be”). The pa-
tient was instructed to regard the VAS as a continuum and 
to make a mark at the point along the line corresponding to 
his/her current level of pain. The score was determined by 
measuring the distance from the left end of the line to the 
patient’s mark. Scoring of VRS-4 consists of a finite list of in-
tensity descriptors: 1 point=“no pain”; 2 points=“a little pain”; 
3 points=“painful, but tolerable”; 4 points=“most pain possible”. 
Measurement of the sympathetic response 
Sympathetic tone, including systolic (SBP) and diastolic blo-
od pressure (DBP), pulse rate (PR), stroke volume (SV) and 
total peripheral resistance (TPR), was measured continuous-
ly and non-invasively by finger photoplethysmography (Fi-
nometer
®; Finapres Medical Systems, Netherlands). Previous 
studies showed that Finometer
® recordings accurately reflect 
the sympathetic response.
10-13)
We defined the sympathetic response as an absolute change 
of sympathetic tone at each step. The finger cuff of the Fino-
meter
® was applied to the mid-phalanx of the middle finger 
on the hand opposite to that with the vascular access site. To 
avoid hydrostatic level differences, the hand was continuously 
Fig. 1. Application of study cream for transradial coronary angiography. Either EMLA or placebo cream was applied to the vascular access 
site (A) and sealed with a transparent cover (B).
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positioned at the right atrial level, in the mid-axillary line. Af-
ter applying the Finometer
®, the patient was stabilized for 5-10 
minutes. We used as baseline values the mean values of sym-
pathetic tone recorded for 1 minute before lidocaine infiltra-
tion. In the pilot phase of our study, we observed that the sym-
pathetic tone started to increase 5-30 seconds after the no-
xious stimulus and decreased immediately after peaking. Be-
cause the time to peak differed among parameters, we used 
the peak value of each sympathetic parameter during the 30-
40 seconds period after lidocaine infiltration, after arterial 
puncture and after introducer sheath insertion. 
Angiographic definition of radial artery spasm
Retrograde radial angiography was performed three times: 
first, after insertion of the introducer sheath (i.e., at the start 
of procedure); second, after injection of 10 mL normal sa-
line with nitroglycerine 200 μg (used as reference diameter); 
third, before withdrawal of the introducer sheath (i.e., at the 
end of procedure).
A 30 to 40-mm long segment from the tip of the introduc-
er sheath at each step was selected to determine the diameter 
of the radial artery, using a computer-assisted quantification 
method (GE
® Medical QCA, USA). We defined the reference 
diameter of the radial artery as the mean diameter of the radi-
al artery after nitroglycerine injection. Angiographic RAS 
was defined as diameter stenosis ≥ 50% of the reference di-
ameter at either the start or the end of procedure, using the fol-
lowing equations: diameter stenosis (DS, %) at the start of the 
procedure={reference diameter (RD)-minimal radial artery 
diameter (MD) after inserting sheath introducer}/RD×100 
(%); DS (%) at the end of the procedure=(RD-MD before wi-
thdrawing sheath introducer) /RD×100 (%). 
Clinical definition of radial artery spasm
The operator accessed the RAS on the basis of a question-
naire addressing the following four signs: persistent forearm 
pain, pain response to catheter manipulation, pain response 
to introducer withdrawal and difficult catheter manipulation 
after being trapped by the radial artery. Clinical RAS was de-
fined as presence of at least 2 of these 4 signs or as the need, as 
determined by the operator, to administer a second dose of 
the spasmolytic agent. 
Statistical analysis
Because there were no data for sympathetic response dur-
ing TRA, we calculated the sample size for testing whether 
the EMLA cream reduces RAS during TRA based on a RAS 
incidence of 20% for the control group and 5% for the EMLA 
group, according to the results of previous studies.
5)6) For in-
equality tests of the two proportions with a power of 80% and 
a two-sided α level of 0.05, we estimated that 36 subjects were 
needed in each group.
The statistical analysis was performed with the SPSS ver-
sion 15 software (SPSS, Inc., Chicago, IL, USA). Continuous 
variables were expressed as mean±standard deviation, and 
categorical data as numbers (percentages). To compare values 
between the two groups, we used the Student’s t-test for conti-
nuous variables or the chi-square test for categorical variables.
Results
Baseline characteristics 
A total of 76 patients were enrolled in this study, 38 in each 
group. Patient baseline characteristics, including age, gender, 
Table 1. Baseline characteristics of study participants
EMLA 
group
(n=38)
Control
group
(n=38)
p
Age 55±90 53±80 0.43
Male gender 23 (60.5) 24 (63.2) 1.00
Medical history
    Hypertension 22 (57.9) 17 (44.7) 0.36
    Diabetes 08 (21.1) 09 (23.7) 1.00
    Dyslipidemia 05 (13.2) 12 (31.6) 0.10
    Myocardial infarction 01 (2.6) 02 (5.3) 1.00
    Coronary intervention 02 (5.3) 06 (15.8) 0.26
    Smoking 23 (60.5) 21 (55.3) 0.30
Medication
    Beta blocker 07 (18.4) 07 (18.4) 1.00
    ACE inhibitor or ARB 10 (26.3) 09 (23.7) 1.00
    Calcium channel blocker 02 (5.3) 04 (10.5) 0.67
    Nitrate 15 (39.5) 15 (39.5) 1.00
Approach site
    Left radial artery 22 (57.9) 30 (78.9) 0.08
Angiographic catheter
    Left coronary artery 0.75
        4-Fr Amplatz 10 (26.3) 13 (34.2)
        4-Fr Judkins 11 (28.9) 10 (26.3)
        5-Fr Judkins 17 (44.7) 15 (39.5)
    Right coronary artery 0.82
        4-Fr Amplatz 21 (55.3) 23 (60.5)
        4-Fr Judkins 17 (44.7) 15 (39.5)
Anthropometric data
    Height (cm) 163±800 163±900 0.79
    Weight (kg) 68±11 68±11 0.92
Diameter of radial artery* (mm) 2.42±0.44 2.26±0.46 0.11
*Diameter of radial artery after nitroglycerine injection. ACEi: angio-
tensin converting enzyme inhibitor, ARB: angiotensin II receptor 
blocker, BMI: body mass index, BSA: body surface area, CO: cardi-
ac output, DBP: diastolic blood pressure, MAP: mean arterial pres-
sure, PR: pulse rate, TPR: total peripheral resistance, SBP: systolic 
blood pressure, SV: stroke volume, EMCA: eutectic mixture of lo-
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medical history, medication, approach site, angiographic ca-
theter used, anthropometric data, and reference diameter of 
the radial artery, were similar in the two groups. Baseline ch-
aracteristics of study participants are presented in Table 1.
Radial pain score during the procedure
During lidocaine infiltration, the radial pain measured by 
VAS and VRS-4 was significantly lower in the EMLA group 
(VAS: 3.1±1.7 vs. 4.0±1.7, p=0.04; VRS-4: 2.0±0.5 vs. 2.2±0.5, 
p=0.03). However, during insertion of the introducer sheath, 
radial pain was similar in the two groups. Radial pain scores 
during the procedures are presented in Table 2.
Sympathetic response 
Sympathetic tone, including SBP, DBP, PR, SV and TPR 
measurements, were similar in the two groups at every step of 
the procedure. In contrast, from baseline to lidocaine infiltr-
ation, the sympathetic response was significantly blunted in 
the EMLA group (ΔSBP, mm Hg: 5 vs. 13, p<0.01; ΔDBP, mm 
Hg: 2 vs. 7, p=0.03; ΔPR, beat/min: 2 vs. 8, p<0.01, ΔSV, mL: 
3 vs. 21, p<0.01; ΔTPR, mm Hg · L/min: 1.0 vs. 5.9, p<0.01); 
however, the difference, except for the change in SBP from 
lidocaine infiltration to puncture, was no longer present af-
ter lidocaine infiltration. Sympathetic responses from base-
line to lidocaine infiltration, from lidocaine infiltration to 
puncture, and from puncture to sheath insertion, are pre-
sented in Table 3 and Fig. 2.
Radial artery cannulation and spasm
In the EMLA group, the cannulation time was significantly 
Table 2. Radial pain score during the procedure
Pain score EMLA group (n=38) Control group (n=38) p
Visual analogue scale
    During lidocaine infiltration  3.1±1.7 4.0±1.7 0.04
    During introducer sheath insertion 2.5±2.3 3.3±2.5 0.15
4-category verbal rating scale
    During lidocaine infiltration 2.0±0.5 2.2±0.5 0.03
    During introducer sheath insertion 1.8±0.7 2.1±0.8 0.10
EMLA: eutectic mixture of local anesthesia 
Table 3. Sympathetic response from baseline to lidocaine infiltration, from lidocaine infiltration to puncture, and from puncture to sheath in-
sertion
EMLA group (n=38) Control group (n=38) p
ΔSBP (mm Hg)
    From baseline lidocaine infiltration -05±10 -13±12 <0.01
    From lidocaine infiltration to puncture -0±9 0-5±14 0.04
    From puncture to sheath insertion 0-7±12 0-2±13 0.13
ΔDBP (mm Hg)
    From baseline to lidocaine infiltration -2±8 -07±12 0.03
    From lidocaine infiltration to puncture -1±7 0-3±10 0.33
    From puncture to sheath insertion -3±6 -00±10 0.27
ΔPR (beat/min)
    From baseline to lidocaine infiltration -2±4 -08±14 <0.01
    From lidocaine infiltration to puncture -2±5 0-5±16 0.24
    From puncture to sheath insertion -1±4 -0±4 0.24
ΔSV (mL)
    From baseline to lidocaine infiltration -3±6 -21±17 <0.01
    From lidocaine infiltration to puncture -1±8 0-6±14 0.11
    From puncture to sheath insertion -2±5 0-4±11 0.20
ΔTPR (mm Hg · L/min)
    From baseline to lidocaine infiltration -1.0±3.2 -5.9±8.2 <0.01
    From lidocaine infiltration to puncture -0.2±3.4 -1.7±6.7 0.22
    From puncture to sheath insertion -0.8±2.1 -0.1±5.5 0.45
EMLA: eutectic mixture of local anesthesia, DBP: diastolic blood pressure, lido: lidocaine, SBP: systolic blood pressure, SV: stroke volume, PR: 
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shorter (21.0±4.7 seconds. vs. 34.0±9.0 seconds., p<0.01) and 
the number of radial artery cannulations was significantly 
lower (1.21±0.47 vs. 1.50±0.69, p=0.04).
The rate of clinical or angiographic RAS was numerically 
lower in the EMLA group; however, the difference did not re-
ach statistical significance. Although the rate of RAS was simi-
lar in the two groups, the minimal radial artery diameter (MD) 
at the start of procedure was significantly larger (1.78±0.54 
mm vs. 1.51±0.41 mm, p=0.02) and the absolute change of 
diameter stenosis was significantly lower (11.9±8.4% vs. 
18.3±12.7%, p=0.01) in the EMLA group. The results of radial 
artery cannulation and spasm are presented in Table 4.
Discussion
This study showed that the EMLA cream effectively reduc-
es radial pain, and therefore blunts the sympathetic response 
during lidocaine infiltration; it also showed that the EMLA 
cream decreases the reduction of radial artery diameter at the 
start of procedure and therefore improves the cannulation 
success rate.
RAS is the most frequent complication of TRA and can cau-
se significant discomfort to the patient, thereby reducing the 
procedural success rate.
3)4) Even in centers with extensive ex-
perience with the radial approach, RAS can occur in 15 to 30% 
of TRA procedures.
5)6) RAS may be related to radial artery an-
atomical anomalies, small diameter of the radial artery, pro-
longed cannulation, increased ratio of radial artery diameter 
to sheath outer diameter, anticoagulation treatment during ar-
terial cannulation and moderate-to-severe pain during radial 
artery cannulation.
7)14) 
From the viewpoint of pain, radial artery is prone to spasm. 
Because the radial artery has a thick-walled vessel composed 
mainly of smooth muscle cells arranged in concentric layers 
and this marked muscular component of the artery, together 
with the high density of α1 receptors, makes this vessel espe-
cially susceptible to spasm.
8) Therefore, the effort for reduc-
ing radial pain during procedure has an important role in 
Fig. 2. Sympathetic response during the procedure. DIA: diastolic blood pressure (mm Hg), PR: pulse rate (beat/min), SV: stroke volume (mL), 
SBP: systolic blood pressure (mm Hg), TPR: total peripheral resistance (mm HgL/min), EMLA: eutectic mixture of local anesthesia.
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preventing RAS. The radial pain reducing effect of the EMLA 
cream has been documented in several studies.
9)15)16) Our 
study also shows significant reduction in radial pain, as mea-
sured by both VAS and VRS-4. 
But none of the studies have evaluated the relationship be-
tween the pain and the sympathetic response. Our study uni-
quely evaluated the sympathetic response by measuring SBP, 
DBP, PR, SV, and TPR by non-invasive monitoring, and sh-
owed a significantly blunted sympathetic response in the 
EMLA group, during lidocaine infiltration. Certainly there is 
a limitation of our study because we did not measure the 
plasma levels of catecholamines, such as epinephrine and 
norepinephrine. However, these analyses are challenging, lack 
specificity and reproducibility, and present physiological limi-
tations.
17) 
After lidocaine infiltration, however, we could not observe 
the difference in sympathetic response between the two gr-
oups. It is likely because lidocaine infiltration itself reduces ra-
dial pain and therefore the sympathetic response.
18)
The role of adrenergic receptor is well known. The activa-
tion of α receptor results in peripheral vasoconstriction, and 
thus increases peripheral vascular resistance. Finally, these 
facts lead to increase DBP. In contrast, the activation of β re-
ceptors results in increased PR and SV, and thus increased 
cardiac output. Finally, these facts lead to increased SBP. In 
our study, we observed that all parameters related to α or β re-
ceptors were increasing after noxious stimuli. This finding re-
flects that the radial pain has a systemic effect on the patient, 
rather than a local effect on the radial artery.
Our study could not demonstrate a reduction in RAS by the 
EMLA cream. The reasons for this result could be explained 
as follows: First, because we used lidocaine infiltration in the 
two groups, the pain sensitivity would be equalized and this 
could result in no difference in RAS between two groups, es-
pecially after licocaine infiltration. Second, multiple factors 
other than pain, including number of radial artery punctures, 
type of catheter used, total procedure time, and patient’s emo-
tional status, might influence RAS incidence. Third, at the 
planning stage of this study, we calculated the sample size 
expecting 15% difference of RAS between the two groups. 
But the true incidence of RAS in our study was smaller than 
expected. So, if we increased the number of subjects, the sta-
tistical difference would be attained.
Although we could not demonstrate the reduction in RAS 
by the ELMA cream, we could observe the shortening of can-
nulation time and the reduction in the number of radial ar-
tery cannulations in this group. This could be achieved in the 
EMLA group by reducing the narrowing of the radial artery 
diameter at the start of the procedure. 
In conclusion, the EMLA cream, in addition to lidocaine in-
Table 4. Radial artery cannulation and spasm
EMLA group (n=38) Control group (n=38) p
Cannulation
Cannulation time (seconds) 21.0±4.70 34.0±9.00 <0.01
Number of radial artery cannulations 1.21±0.47 1.50±0.69 0.04
First-attempt cannulation success, n (%) 31 (81.6) 23 (60.5) 0.08
At the start of procedure
Angiographic RAS, n (%) 2 (5.3)0 06 (15.8) 0.26
MD (mm) 1.78±0.54 1.51±0.41 0.02
DS (%) 27.1±15.4 32.3±16.4 0.16
ΔDS (%) 11.9±8.40 18.3±12.7 0.01
At the end of procedure
Clinical or angiographic RAS, n (%) 5 (13.2) 09 (23.7) 0.38
Clinical RAS, n (%) 3 (7.9)0 04 (10.5) 1.00
Persistent forearm pain 1 (2.6)0 1 (2.6) 1.00
Pain response to catheter manipulation 2 (5.3)0 3 (7.9) 1.00
Pain response to introducer withdrawal 4 (10.5) 05 (13.2) 1.00
Difficult catheter manipulation 0 (0)00. 1 (2.6) 1.00
Need of 2nd vasodilator injection 1 (2.6)0 2 (5.3) 1.00
Angiographic RAS, n (%) 2 (5.3)0 06 (15.8) 0.26
MD (mm) 1.92±0.57 1.73±0.41 0.14
DS (%) 21.8±20.0 20.5±21.1 0.81
ΔDS (%) 04.2±18.7 04.4±20.9 0.97
EMLA: eutectic mixture of local anesthesia, DS: diameter stenosis, MD: minimal diameter, RAS: radial artery spasm, SD: standard deviation732   EMLA Cream During Transradial Coronary Angiography
filtration, effectively reduces the radial pain, and thus the 
sympathetic response, during lidocaine infiltration. With 
this benefit, the ELMA cream reduces the narrowing of the 
radial artery diameter at the start of procedure, and thus im-
proves the cannulation in patients undergoing TRA.
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